StockNews.com initiated coverage on shares of Perrigo (NYSE:PRGO – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a buy rating on the stock. A number of other equities analysts also recently commented on PRGO. Canaccord Genuity Group assumed coverage on Perrigo in a research report on Tuesday, March 7th. […]
StockNews.com initiated coverage on shares of Perrigo (NYSE:PRGO – Get Rating) in a research report report published on Thursday. The brokerage issued a buy rating on the stock. A number of other equities analysts have also commented on the stock. Raymond James increased their price target on shares of Perrigo from $42.00 to $43.00 and […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) was the target of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 129,800 shares, a decrease of 30.3% from the April 15th total of 186,200 shares. Approximately 6.7% of the shares of the company are sold […]
Better Therapeutics, Inc. (NASDAQ:BTTX – Get Rating) was the recipient of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 129,800 shares, a decrease of 30.3% from the April 15th total of 186,200 shares. Currently, 6.7% of the company’s shares are short sold. Based […]
Everi (NYSE:EVRI – Get Rating) had its price target lowered by B. Riley from $31.00 to $27.00 in a report released on Thursday morning, The Fly reports. A number of other research analysts have also recently issued reports on EVRI. 58.com reissued a maintains rating on shares of Everi in a research note on Tuesday, […]